Turnaround and Transformation Survey

Companies in many regions remain mired in challenges driven by the rapid rise in the cost of capital. Criticaleye Partner AlixPartners' 19th Annual Turnaround and Transformation Survey sees more than 700 of the world's restructuring experts, and executives say that the cost of capital is still the biggest factor driving company distress. However, that is just one part of the emerging story.

Key Takeaways Include:

  • Which sector globally is most likely to face distress in 2024? 
  • 82 percent expect the cost of capital to remain at current levels or increase further, while 18 percent expect it to decrease.
  • 72 percent say restructuring capital structure or moving assets is the most likely liability management technique to be activated in the next 12 months to mitigate risk.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
From Implementer to Influence...

CPOs are facing added pressures as they navigate the people side of business transformation. This report by Criticaleye Partner LACE Partners looks at HR’s role in business transformation, the challenges CPOs face...

Inspiring Leaders Podcast: Su...

Martin Balaam, CEO of Pimberly and Jacqui Summons, NED/Fractional CHRO join Criticaleye's Senior Editor, Jacob Ambrose Willson to explore the demands of private equity ownership from driving value creation and manag...

Click here to download this insight
Bringing Appreciation to Life

When it comes to employee appreciation, the most successful organisations find ways to address a wide range of their employees’ needs. This report by Criticaleye Partner Reward Gateway | Edenred explores...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 422




Eightfold AI IBM Consulting Google Legal & General London Stock Exchange Group British Land AlixPartners Worldpay Lightsource bp Concentrix Accenture Rolls-Royce Palo Alto Networks Salesforce Drax Group plc Aldermore Group NatWest Group Hitachi Solutions GlaxoSmithKline plc NATS Workday FTSE Women Leaders Review E.ON UK